期刊文献+

肿瘤坏死因子β水平与多发性硬化临床表现的相关性

Association between the level of tumor necrosis factor β and the clinical features of multiple sclerosis
下载PDF
导出
摘要 目的探讨肿瘤坏死因子(TNF)β水平与多发性硬化(MS)临床表现的相关性。方法应用双抗体夹心酶联免疫法测定58例MS患者(MS组)血清TNFβ水平;并与患者不同亚型、病期、神经功能缺损程度的扩展病残状态评分(EDSS)、病程、发病次数、发病年龄等临床情况进行相关性分析。结果(1)MS组急性期TNFβ水平较缓解期和正常对照组显著升高(P〈0.05-0.01);MS缓解期与正常对照组间差异无统计学意义。(2)MS西方型急性期TNFβ水平较缓解期显著升高(P〈0.01);MS亚洲型急性期与缓解期差异无统计学意义。(3)两亚型急性期、缓解期TNFβ水平与其EDSS、病程、发病次数及发病年龄均无相关性。结论(1)TNFβ水平与MS急性期存在相关,MS西方型急性期、缓解期变化更显著。(2)TNFβ水平与EDSS、病程、发病次数及发病年龄可能不相关。 Objective To investigate the relationship between the level of tumor necrosis factor (TNF) β and the clinical features of multiple sclerosis ( MS ). Methods The TNFβ level of 58 MS patients ( MS group ) was determined by means of sandwich enzyme-linked immunosorbent assay (ELISA). The correlative analysis between level of TNFβ and the Expanded Disability Status Scale ( EDSS ), the clinical data ( including the duration of disease,the number of relapses and the age of onset) were take in MS patients. Results ( 1 ) TNFβ level was significantly increased in MS acute stage compared with those in MS remission stage and healthy controls (P 〈 0.05 - 0.01 ), but there was no significant different between MS remission stage and healthy controls. (2)The TNFβ level of acute stage was significantly higher than that of remission stage in MS Western-type( P 〈 0.05 ) , but not in MS Asian-type. (3)There was no significant positive correlation of TNFβ level of MS acute or remission stage in both sub-types to EDSS, the duration of disease, the number of relapses and the age of onset. Conclusions ( 1 ) There is significant association between the level of TNFβ and MS acute stage, especially in MS Western-type. (2)There is no positive correlation of TNFβ levels to EDSS, the duration of disease, the number of relapses and the age of onset.
出处 《临床神经病学杂志》 CAS 北大核心 2008年第3期189-191,共3页 Journal of Clinical Neurology
基金 河北省卫生厅技术跟踪资助项目(200402)
关键词 肿瘤坏死因子Β 多发性硬化 tumor necrosis factor beta multiple sclerosis
  • 相关文献

参考文献10

  • 1Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols [ J ]. Ann Neurol,1983, 13 : 227.
  • 2Kira J, Kanai T,Nishimura Y, et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders[J]. Ann Neurol, 1996, 40: 569.
  • 3Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale(EDSS) [ J]. Neurology, 1983,33 : 1444.
  • 4田作军,赵薛旭,李作汉.细胞因子及受体在不同病期多发性硬化发病机制中的作用[J].临床神经病学杂志,2001,14(5):317-319. 被引量:2
  • 5罗丽,周红雨.多发性硬化复发的生物学指标检测[J].中国神经免疫学和神经病学杂志,2006,13(4):246-249. 被引量:3
  • 6周文斌,崔玉真,肖波.多发性硬化的流行病学研究(综述)[J].中国神经免疫学和神经病学杂志,2005,12(6):373-375. 被引量:25
  • 7Kenealy SJ, Pericak-Vance MA, Haines JL. The genetic epidemiology of multiple sclerosis[ J]. J Neuroimmunology, 2003, 143 : 7.
  • 8McDevitt H, Munson S, Ettinger R, et al. Multiple roles for tumor necrosis factor-alpha and lymphotoxin alpha/beta in immunity and autoimmunity[ J]. Arthritis Res, 2002, 4 : 141.
  • 9郭力,张静,李彬,董惠,李春岩.肿瘤坏死因子β及其基因多态性与吉兰-巴雷综合征的相关性研究[J].中国神经精神疾病杂志,2006,32(2):138-141. 被引量:4
  • 10Riese J, Woerner K, Zimmermann P, et al. Association of TNFβ gene polymorphism with complications after major abdominal operations[ J ]. Strock,2003,34 : 1.

二级参考文献70

  • 1王晓娟,吴立克,李春岩.脑囊虫病患者脑脊液中一氧化氮及肿瘤坏死因子α水平研究[J].中国神经精神疾病杂志,2004,30(4):255-257. 被引量:3
  • 2成军,郭素芹,郭敬华,李强,李红,杜海霞,郭芳.利培酮及氯氮平对儿童精神分裂症血清α-肿瘤坏死因子的影响[J].中国神经精神疾病杂志,2006,32(1):43-45. 被引量:2
  • 3胡学强,黎锦如,潘勇辉,黄秋云,雷振宏,刘天琪.广东省容奇镇多发性硬化患病率调查[J].中山医科大学学报,1997,18(1):79-80. 被引量:7
  • 4Kurtzke JF.Mutiple sclerosis in time and spacegeographic clues to cause [J] .J Neurovirol,2000,2(suppl 6):s134-s140.
  • 5Savettleri G,Ragoncse P,Aridon P,et al.Epidemiology of mutiple sclerosis in Sicily[J].Neurol Sci,2001,22(2):175-177.
  • 6Svenson L,Warren S,Warren K.G,et al.Update on the incidence and prevalence of mutiple sclerosis in Alberta,Canada [J].Neuroepidemiology,2003,22:159.
  • 7Lau KK,Wong LK,Li LS,et al.Epidemiologieal study of mutiple sclerosis in Hong Kong Chinese:questionnaire survey [J].Hong Kong Med J,2002,8(2):77-80.
  • 8Karni A,Kahana E,Zilber N,et al.The frenquency of mutiple sclerosis in Jewish and Arab population in greater Jerusalem [J].Neuroepidemiology,2003,22(1):82-86.
  • 9Drew PD,Chavis JA,Bhatt R.Sex steroid regulation of microglial cell activation:relevance to mutiple sclerosis[J].Ann NY Acad Sci,2003,1007:329-334.
  • 10Pinhas-Hamiel O,Sarova-Pinhas I,Achiron A.Mutiple sclerosis in childhood and adolescence:clinical features and management[J].Paediatr Drugs,2001,3(5):329-336.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部